HK1213051A1 - 用於预测和监测粘膜愈合的方法 - Google Patents

用於预测和监测粘膜愈合的方法 Download PDF

Info

Publication number
HK1213051A1
HK1213051A1 HK16100852.9A HK16100852A HK1213051A1 HK 1213051 A1 HK1213051 A1 HK 1213051A1 HK 16100852 A HK16100852 A HK 16100852A HK 1213051 A1 HK1213051 A1 HK 1213051A1
Authority
HK
Hong Kong
Prior art keywords
mucosal healing
predicting
monitoring
methods
present
Prior art date
Application number
HK16100852.9A
Other languages
English (en)
Chinese (zh)
Inventor
Sharat Singh
Xinjun Liu
Scott Hauenstein
Richard Kirkland
Katherine DRAKE
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of HK1213051A1 publication Critical patent/HK1213051A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16100852.9A 2012-10-05 2013-10-02 用於预测和监测粘膜愈合的方法 HK1213051A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261710491P 2012-10-05 2012-10-05
US201261710491P 2012-10-05
US201361824959P 2013-05-17 2013-05-17
US201361824959P 2013-05-17
PCT/IB2013/059077 WO2014054013A1 (en) 2012-10-05 2013-10-02 Methods for predicting and monitoring mucosal healing

Publications (1)

Publication Number Publication Date
HK1213051A1 true HK1213051A1 (zh) 2016-06-24

Family

ID=49447587

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100852.9A HK1213051A1 (zh) 2012-10-05 2013-10-02 用於预测和监测粘膜愈合的方法

Country Status (11)

Country Link
US (1) US20150355195A1 (cg-RX-API-DMAC7.html)
EP (3) EP3640645A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015532425A (cg-RX-API-DMAC7.html)
CN (1) CN104838270A (cg-RX-API-DMAC7.html)
AU (2) AU2013326070A1 (cg-RX-API-DMAC7.html)
CA (1) CA2887035A1 (cg-RX-API-DMAC7.html)
ES (2) ES2638971T3 (cg-RX-API-DMAC7.html)
HK (1) HK1213051A1 (cg-RX-API-DMAC7.html)
MX (1) MX358730B (cg-RX-API-DMAC7.html)
SG (1) SG11201502646RA (cg-RX-API-DMAC7.html)
WO (1) WO2014054013A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3295783A1 (en) 2011-05-10 2026-03-02 Prometheus Laboratories, Inc. Methods of disease activity profiling for personalized therapy management
WO2016063223A1 (en) * 2014-10-20 2016-04-28 Nestec S.A. Methods for predicting clinical outcomes in subjects afflicted with ulcerative colitis
US20170258820A1 (en) 2014-10-29 2017-09-14 Glycom A/S Synthetic composition and method for promoting mucosal healing
GB201501612D0 (en) * 2015-01-30 2015-03-18 Univ Birmingham Assay
CN109462996A (zh) 2016-03-17 2019-03-12 西达-赛奈医疗中心 通过rnaset2诊断炎性肠病的方法
GB201611738D0 (en) * 2016-07-05 2016-08-17 Cambridge Entpr Ltd Biomarkers for inflammatory bowel disease
KR20200009095A (ko) * 2017-05-31 2020-01-29 프로메테우스 바이오사이언시즈, 인크. 크론병 환자에서 점막 치유를 평가하는 방법
WO2020112890A1 (en) 2018-11-29 2020-06-04 Cedars-Sinai Medical Center Rnaset2 compositions and methods of treatment therewith
CN110646620A (zh) * 2019-09-29 2020-01-03 湖北新纵科病毒疾病工程技术有限公司 一种同时检测四项炎症标志物的方法及其试剂盒
CN111477325A (zh) * 2020-04-09 2020-07-31 赣南师范大学 基于粒子群优化算法对引发肠道溃疡疾病进行鉴别的方法
CN120600283B (zh) * 2025-05-29 2026-02-17 北京大学第三医院(北京大学第三临床医学院) 一种基于临床知识图谱的中医生殖内分泌疾病诊断辅助系统

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830675A (en) 1993-03-10 1998-11-03 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
EP0615129B1 (en) 1993-03-10 2000-05-31 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis or primary sclerosing cholangitis
US6218129B1 (en) 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
US6406862B1 (en) 1998-10-06 2002-06-18 The United States Of America As Represented By The Secretary Of The Army Dip-stick assay for C-reactive protein
FR2802536B1 (fr) 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
US6838250B2 (en) 2000-03-31 2005-01-04 Ortho-Clinical Diagnostics, Inc. Immunoassay for C-reactive protein
AU2001253746A1 (en) * 2000-04-20 2001-11-07 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Inducible plasmid vector encoding tgf-beta and uses thereof
US7138237B1 (en) 2000-05-19 2006-11-21 Cedars-Sinai Medical Center Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
EP1581119B1 (en) 2001-12-17 2013-01-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
US20040197304A1 (en) * 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
CA2549971A1 (en) 2003-11-03 2005-05-12 Duke University Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
WO2006012472A1 (en) 2004-07-21 2006-02-02 Qualyst, Inc. Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation
WO2007087576A2 (en) 2006-01-24 2007-08-02 The Uab Research Foundation Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
CN104198705B (zh) 2006-09-21 2017-06-09 雀巢产品技术援助有限公司 检测稀有循环细胞内多种信号转导分子的基于抗体的阵列
NZ582618A (en) 2007-07-13 2012-07-27 Prometheus Lab Inc Drug selection for lung cancer therapy using antibody-based arrays
ES2553390T3 (es) 2008-02-25 2015-12-09 Nestec S.A. Método para la detección de receptores truncados intracelulares
CN101780269A (zh) * 2009-01-21 2010-07-21 北京三有利科技发展有限公司 细胞生长因子治疗溃疡性疾病和肺纤维化疾病的应用
NZ596468A (en) 2009-05-14 2013-11-29 Nestec Sa Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
JP5795311B2 (ja) 2009-07-15 2015-10-14 ネステク ソシエテ アノニム 抗体ベースのアレイを使用する胃癌療法のための薬物選択
DK2491385T3 (en) 2009-10-20 2017-08-28 Diatech Holdings Inc PROXIMITY-MEDIED ASSAYS FOR DETECTING ONCOGEN FUSION PROTEINS
CN104634955B (zh) 2009-10-26 2016-09-14 雀巢产品技术援助有限公司 检测抗-tnf药物和自身抗体的试验
CA2781654A1 (en) * 2009-11-25 2011-06-03 Hua Gong Novel genomic biomarkers for irritable bowel syndrome diagnosis
EP2576838A4 (en) * 2010-06-04 2019-05-15 Nestec S.A. METHOD FOR IMPROVING DIAGNOSIS OF INFLAMMATORY ENDURANCE
WO2012054532A1 (en) 2010-10-18 2012-04-26 Prometheus Laboratories Inc. Methods for determining anti-drug antibody isotypes
SG191230A1 (en) 2010-12-23 2013-07-31 Nestec Sa Drug selection for malignant cancer therapy using antibody-based arrays
MX343327B (es) 2011-02-17 2016-11-01 Nestec Sa Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
EP2681552A2 (en) 2011-03-02 2014-01-08 Nestec S.A. Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures
WO2013006810A1 (en) 2011-07-06 2013-01-10 Nestec Sa Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha
KR101851425B1 (ko) 2011-09-02 2018-04-23 네스텍 소시에테아노님 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링

Also Published As

Publication number Publication date
AU2019204276A1 (en) 2019-07-04
CA2887035A1 (en) 2014-04-10
ES2771127T3 (es) 2020-07-06
MX2015004272A (es) 2015-08-14
CN104838270A (zh) 2015-08-12
AU2013326070A1 (en) 2015-04-23
EP3217179A1 (en) 2017-09-13
ES2638971T3 (es) 2017-10-24
SG11201502646RA (en) 2015-05-28
EP3217179B1 (en) 2020-01-08
EP2904405B1 (en) 2017-05-31
EP3217179B9 (en) 2020-06-10
EP3640645A1 (en) 2020-04-22
MX358730B (es) 2018-09-03
WO2014054013A1 (en) 2014-04-10
US20150355195A1 (en) 2015-12-10
EP2904405A1 (en) 2015-08-12
JP2015532425A (ja) 2015-11-09

Similar Documents

Publication Publication Date Title
MX358730B (es) Metodos para predecir y monitorear cicatrizacion de la mucosa.
EP3065777A4 (en) Methods of use for il-22 in the treatment of gastrointestinal graft vs. host disease
IL261313B (en) Methods of identification and diagnosis of lung disease using classification systems and kits thereof
WO2012166626A8 (en) Reagents and methods for treating dental disease
PH12014500903A1 (en) Bispecific immunobinders directed against tnf and il-17
HK1205964A1 (en) Kit and devices for organ perfusion
WO2012006538A8 (en) Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
EP2742155A4 (en) BIOMARKER FOR ALZHEIMER'S DISEASE AND / OR COGNITIVE LIGHT DISORDER, AND USE THEREOF
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
EP3055803A4 (en) Clinical outcome tracking and analysis
HUE045629T2 (hu) Készítmények, alkalmazások és eljárások anyagcsere rendellenességek és betegségek kezelésére
WO2014031487A8 (en) Bivalent inhibitors of iap proteins and therapeutic methods using the same
CA2868551C (en) Methods and compositions for treating inflammation
WO2013106273A3 (en) Peptides and methods of using same
FR2969577B1 (fr) Aeronef muni d'un rotor arriere basculant, et procede associe
DK2397706T3 (da) Magasinstrimmel.
HK1209035A1 (en) Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta
EA201691314A1 (ru) Терапевтические способы и композиции
WO2013028554A3 (en) Gene signatures for lung cancer prognosis and therapy selection
HK1205198A1 (en) Prediction of treatment response to jak/stat inhibitor
EP3061020A4 (en) Pathogenicity scoring system for human clinical genetics
WO2012075069A3 (en) Signatures and determinants associated with cancer and methods of use thereof
WO2013055418A3 (en) Cross-protective arenavirus vaccines and their method of use
HK1225298A1 (zh) Cd6结合配对体的使用和以其为基础的方法
WO2014107718A3 (en) Heat shock protein (hsp) inhibition and monitoring effectiveness thereof